SP3-25903-41548
2 vaccinations
3 coded responses
15 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 980 / WA
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 1 — Pfizer-BioNTech
- 2021-04-12
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-15
- 2021-04-16
- 2021-04-19
- 2021-04-28
-
2021-05-03
Survey response — day 21, dose 1MedDRA: Tinnitus — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-06
Dose 2 — Pfizer-BioNTech
- 2021-05-18
- 2021-05-20
- 2021-05-27
-
2021-06-03
Survey response — day 28, dose 2MedDRA: Herpes simplex, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Reactivating of herpes. Last time I had it was 6 years agoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-03
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-08
- 2021-06-17
- 2021-11-04
-
2022-05-06
Survey response — 12 months, dose 2MedDRA: Neuropathy peripheral — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Neuropathy in feet.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-09
- 2022-05-09
- 2022-05-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Pfizer-BioNTech | |
| 2 | 2021-05-06 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 8 — day 21, dose 1
Symptoms: Tinnitus
Release 8 — day 28, dose 2
Symptoms: Reactivating of herpes. Last time I had it was 6 years ago
Release 11 — 12 months, dose 2
Symptoms: Neuropathy in feet.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Herpes simplex | ✓ | ✓ | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release